Figure 1.

Discrimination estimates for each prognostic model by country. Confidence intervals, when reported, are presented in Online Table 1. In Acevedo [19], the outcome was cardiovascular mortality (did not include nonfatal events). Brown dots represent studies conducted with populations in 1 country alone, and orange dots are for multicountry studies. PROCAM is a prognostic model for men, the “PROCAM (sex)” indicates the adjusted model so that it can be used for men and women. Figure template from http://yourfreetemplates.com (see “Details for preparation of Figure 1” in the Online Appendix). ACC/AHA, American College of Cardiology/American Heart Association; CHA₂DS₂VASc, Congestive Heart Failure, Hypertension, Age ≥75 Years, Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack or Thromboembolism, Vascular Disease, Age 65 to 74 Years, Sex; CUORE, Continuous Ultrafiltration for Congestive Heart Failure; FC-IHRS, fasting cholesterol INTERHEART risk score; INTERHEART, Effect of Potentially Modifiable Risk Factors Associated With Myocardial Infarction in 52 Countries; NL-IHRS, nonlaboratory INTERHEART risk score; PROCAM, Prospective Cardiovascular Münster.